human single-chain variable fragment (scfv) antibody phage library (IONTAS Ltd)
Structured Review

Human Single Chain Variable Fragment (Scfv) Antibody Phage Library, supplied by IONTAS Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+single-chain+variable+fragment+(scfv)+antibody+phage+library/1+antibody+phage+display+library/pmc07329857-49-2-1
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies"
Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies
Journal: Scientific Reports
doi: 10.1038/s41598-020-67654-7
Figure Legend Snippet: Binding and neutralizing capability of the scFv clones discovered using phage display and a cross-panning strategy against CTxs from African cobras. ( a ) In direct ELISA, 113 cross-binding scFv clones recognized both Nn 18 and Nn 20 venom fractions. Fraction 8 from Dendroaspis polylepis venom (Dp 8, Dendrotoxin 1) was used as a negative control. ( b ) Seven of the unique cross-binding scFv clones bound five different CTxs-containing fractions from three different cobra species (Nn 18, Nn 20, Nn 25, Nmo 13, and Nm 17). Bars represent mean ± SD of triplicate wells. ( c ) Different amounts of venom fractions (2–80 µg/mL) were added to N/TERT cells. After 24 h of incubation at 37 °C, cell viability was determined by quantifying the ATP release into the culture media, and mean cell survival percentage was calculated from triplicate wells. The half-maximal inhibitory concentration (IC 50 ) was determined by fitting the mean cell survival percentage of inhibition-concentration data into a Hill equation and has been represented as values ± standard error. ( d ) Neutralization of the cytolytic effects of the venom fractions on human N/TERT cells by the discovered broadly-neutralizing TPL0027_01_F7 scFv antibody. 2 IC 50 of the venom fractions were pre-incubated with TPL0027_01_F7. The scFv antibody TPL0039_05_E2, targeting the unrelated Myotoxin II from Bothrops asper venom, was used as a negative control. Experiments were performed in triplicates, and results are expressed as mean ± SD. One-way analysis of variance (ANOVA) followed by Tukey’s post hoc test was performed for each group, except the Nn 18 group, and p < 0.05 was considered to be of statistical significance. For the Nn 18 group, a one-way ANOVA could not be carried out because the group only contained two samples, therefore, an unpaired t test was carried out with p < 0.05 considered to be of statistical significance. For each of the five fractions, there was a statistically significant difference between “fraction + TPL0027_01_F7” and “fraction”. For the four groups containing the “fraction + TPL0035_09_E2”, there was a statistically significant difference between this and “fraction + TPL0027_01_F7”. However, differences between “fraction” and “fraction + TPL0035_09_E2” were not statistically significant for any of the four groups. *Insufficient amounts, this fraction was not available for testing.
Techniques Used: Binding Assay, Clone Assay, Direct ELISA, Negative Control, Combined Bisulfite Restriction Analysis Assay, Incubation, Concentration Assay, Inhibition, Neutralization
Related Articles
Binding Assay:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The Clone Assay:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The Direct ELISA:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The Negative Control:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The Combined Bisulfite Restriction Analysis Assay:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The Incubation:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The Concentration Assay:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The Inhibition:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The Neutralization:Article Title: An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies Article Snippet: The |